What are the key points of San Shang Life's latest board changes?

Most directors re-elected for the 12th term, with Hsu Qing-Zhengxin newly appointed as director.

What is the background of new director Hsu Qing-Zhengxin?

Chief Legal & Sustainability Officer at San Shang Investment Holding, experienced in corporate law and ESG.

Will this change affect company operations?

No major impact, as turnover rate is below one-third and most directors continue.

What is the shareholding status of the directors?

Corporate reps hold 1.836 billion shares each; Hsu holds 415,219 shares; others have zero.

When does the new board take effect?

The new board took office on June 26, 2026 (Minguo 115/06/26).

San Shang Life Insurance Announces Elected Members of 12th Board of Directors (Including Independent Directors)

Published Jun 26, 2026 9:00 AM ・ Updated Jun 27, 2026 5:33 PM ・ 10 min read ・ Source: PR Times

San Shang Life Insurance announces the results of its 12th Board of Directors election, with most incumbent directors re-elected. Hsu Qing-Zhengxin has been newly appointed as director, ensuring continued governance stability.

1. Date of Change: 115/06/26

2. Category of Personnel Elected or Changed (please enter Corporate Director, Corporate Supervisor, Independent Director, Individual Director, or Individual Supervisor): Corporate Director, Independent Director, Individual Director

3. Previous Directors’ Titles and Names: Chairman: San Shang Investment Holding Co., Ltd. Representative: Weng Zhao-Xi Director: San Shang Investment Holding Co., Ltd. Representative: Weng Wei-Jun Director: San Shang Investment Holding Co., Ltd. Representative: None Director: San Shang Investment Holding Co., Ltd. Representative: Cai Yong-Yi Director: Chen Xiang-Li Director: Zheng Chun-Nong Director: Wang Zhi-Hua Independent Director: Yang Hong-Yi Independent Director: Guo Wei-Yu Independent Director: Du De-Cheng Independent Director: Liu Han-Zong

4. Previous Directors’ Resumes: San Shang Investment Holding Co., Ltd. Representative: Weng Zhao-Xi / Chairman, Taiwan Celebrity Golf Promotion Foundation San Shang Investment Holding Co., Ltd. Representative: Weng Wei-Jun / Chairman, Aseptis Pharmaceutical Technology Corp. San Shang Investment Holding Co., Ltd. Representative: None San Shang Investment Holding Co., Ltd. Representative: Cai Yong-Yi / Independent Director, GYI Group Co., Ltd. Chen Xiang-Li / Chairman & CEO, San Shang Investment Holding Co., Ltd. Zheng Chun-Nong / Certified Public Accountant, Liangdong Accounting Firm Wang Zhi-Hua / Financial Officer, San Shang Investment Holding Co., Ltd. Yang Hong-Yi / General Manager, RGA Reinsurance Company Taiwan Branch Guo Wei-Yu / Distinguished Professor, Department of International Business and Trade, National Chengchi University Du De-Cheng / Chairman, Lihbao New Drug Biotechnology Corp. Liu Han-Zong / Director, Sino-Canada Investment Development Corp.

5. New Directors’ Titles and Names: Director: San Shang Investment Holding Co., Ltd. Representative: Weng Zhao-Xi Director: San Shang Investment Holding Co., Ltd. Representative: Weng Wei-Jun Director: San Shang Investment Holding Co., Ltd. Representative: Cai Yong-Yi Director: Chen Xiang-Li Director: Zheng Chun-Nong Director: Xu (Qing-Zheng) Xin Independent Director: Yang Hong-Yi Independent Director: Du De-Cheng Independent Director: Liu Han-Zong

6. New Directors’ Resumes: San Shang Investment Holding Co., Ltd. Representative: Weng Zhao-Xi / Chairman, Taiwan Celebrity Golf Promotion Foundation San Shang Investment Holding Co., Ltd. Representative: Weng Wei-Jun / Chairman, Aseptis Pharmaceutical Technology Corp. San Shang Investment Holding Co., Ltd. Representative: Cai Yong-Yi / Independent Director, GYI Group Co., Ltd. Chen Xiang-Li / Chairman & CEO, San Shang Investment Holding Co., Ltd. Zheng Chun-Nong / Certified Public Accountant, Liangdong Accounting Firm Xu (Qing-Zheng) Xin / Chief Legal Officer & Chief Sustainability Officer, San Shang Investment Holding Co., Ltd. Yang Hong-Yi / General Manager, RGA Reinsurance Company Taiwan Branch Du De-Cheng / Chairman, Lihbao New Drug Biotechnology Corp. Liu Han-Zong / Director, Sino-Canada Investment Development Corp.

7. Nature of Change (please enter 'Resignation', 'Dismissal', 'End of Term', 'Deceased', or 'New Appointment'): End of Term

8. Reason for Change: Election of 12th Board of Directors

9. Shareholding of Newly Appointed Directors at Time of Election: Director: San Shang Investment Holding Co., Ltd. Representative: Weng Zhao-Xi / 1,836,519,880 shares Director: San Shang Investment Holding Co., Ltd. Representative: Weng Wei-Jun / 1,836,519,880 shares Director: San Shang Investment Holding Co., Ltd. Representative: Cai Yong-Yi / 1,836,519,880 shares Director: Chen Xiang-Li / 0 shares Director: Zheng Chun-Nong / 0 shares Director: Xu (Qing-Zheng) Xin / 415,219 shares Independent Director: Yang Hong-Yi / 0 shares Independent Director: Du De-Cheng / 0 shares Independent Director: Liu Han-Zong / 0 shares

10. Previous Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/06/15 ~ 115/06/14

11. Effective Date of New Appointment: 115/06/26

12. Director Turnover Rate During Same Term: Not Applicable

13. Independent Director Turnover Rate During Same Term: Not Applicable

14. Supervisor Turnover Rate During Same Term: Not Applicable

15. Is the Change in Directors More Than One-Third (Yes or No): No

16. Other Matters to be Disclosed (if the subject is a publicly issued company or above, this material information also meets the criteria under Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act regarding matters significantly affecting shareholders’ rights or securities prices): None

FACT BOX

Source: PR Times
Category: 人事
Dates in source: 115/06/26 / 112/06/15

San Shang Life Insurance Announces Elected Members of 12th Board of Directors (Including Independent Directors)

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY